AML1/ETO Expresssion in Myeloid Leukemia Cells Is Associated with Enhanced Growth-Inhibitory and P15/INK4b Demethylating Effects of 5-AZA-2′-Deoxycytidine

MLA

Manfred Fliegauf, et al. “AML1/ETO Expresssion in Myeloid Leukemia Cells Is Associated with Enhanced Growth-Inhibitory and P15/INK4b Demethylating Effects of 5-AZA-2′-Deoxycytidine.” Blood, vol. 104, Nov. 2004, p. 1165. EBSCOhost, https://doi.org/10.1182/blood.v104.11.1165.1165.

APA

Manfred Fliegauf, Yalin Guo, Michael Lübbert, Tobias Berg, & Mahmoud Abdelkarim. (2004). AML1/ETO Expresssion in Myeloid Leukemia Cells Is Associated with Enhanced Growth-Inhibitory and P15/INK4b Demethylating Effects of 5-AZA-2′-Deoxycytidine. Blood, 104, 1165. https://doi.org/10.1182/blood.v104.11.1165.1165

Chicago

Manfred Fliegauf, Yalin Guo, Michael Lübbert, Tobias Berg, and Mahmoud Abdelkarim. 2004. “AML1/ETO Expresssion in Myeloid Leukemia Cells Is Associated with Enhanced Growth-Inhibitory and P15/INK4b Demethylating Effects of 5-AZA-2′-Deoxycytidine.” Blood 104 (November): 1165. doi:10.1182/blood.v104.11.1165.1165.